Outlook Therapeutics, Inc. (OTLK) Insider Trading
Sector: Biotechnology · Market Cap: $140M · 1 insider purchase in the last 7 days
| INSIDER | DATE | SHARES | PRICE | TOTAL VALUE | OWNED AFTER | Δ OWNED | FILING |
|---|---|---|---|---|---|---|---|
| Sukhtian Ghiath M. Director | Aug 12, 2026 | 2,525,252 | $0.99 | $2.5M | 24,617,320 | +11.4% |
Want more?
Sign up free to see 30+ days of history, set alerts, and track OTLK on your watchlist.
Start for FreeAbout Outlook Therapeutics, Inc. Insider Trading
2 insiders at Outlook Therapeutics, Inc. (OTLK) have purchased stock in the past 90 days, totaling $2.6M across 2 transactions (2,620,650 shares).
The most recent purchase was by Director Sukhtian Ghiath M. on August 12, 2026 — a $2.5M buy of 2,525,252 shares at $0.99, bringing his total holdings to 24,617,320 shares.
Insiders who purchased: Sukhtian Ghiath M. (Director, 1 buy totaling $2.5M); Sukhtian Faisal Ghiath (Director, 1 buy totaling $100K).
This insider buying is notable given that OTLK had no recorded open market purchases in the nine months before that.
OTLK is in the Biotechnology sector within the Biotechnology industry with a market cap of $140M.
Track OTLK insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.